Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons

New England Journal of Medicine

Volumn 321, Issue 24, 1989, Pages 1621-1625

  ho, David D ^a   Moudgil, Tarsem ^a   Alam, Masud ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0024805742     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198912143212401     Document Type: Article

References (17)

1. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868–71.
2. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224: 497–500.
3. Klatzmann D, Barré-Sinoussi F, Nugeyre MT, et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984; 225: 59–63.
4. Ho DD, Rota TR, Hirsch MS. Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest 1986; 77: 1712–5.
5. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986; 223: 215–9.
6. Ehrnst A, Sonnerborg A, Bergdahl S, Strannegard O. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol 1988; 26: 23–32.
7. Zagury D, Bernard J, Leibowitch J, et al. HTLV-HI in cells cultured from semen of two patients with AIDS. Science 1984; 226: 449–51.
8. Ho DD, Schooley RT, Rota TR, et al. HTLV-III in the semen and blood of a healthy homosexual man. Science 1984; 226: 451–3.
9. Vogt MW, Witt DJ, Craven DE, et al. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986; 1: 525–7.
10. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cere-brospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985; 313: 1493–7.
11. Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A 1986; 83: 772–6.
12. Salahuddin SZ, Markham PD, Popovic M, et al. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A 1985; 82: 5530–4.
13. Duesberg PH. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc Natl Acad Sci U S A 1989; 86: 755–64.
14. Fauci AS. Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A 1986; 83: 9278–83.
15. Ho DD, Pomerantz RJ, Kaplan JC. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 1987; 317: 278–86.
16. Perkins HA, Samson S, Gamer J, et al. Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS. Blood 1987; 70: 1604–10.
17. McCray E, Cooperative Needlestick Surveillance Group. Occupational risk of the acquired immunodeficiency syndrome among health care workers. N Engl J Med 1986; 314: 1127–32.